This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, eHealth) (353) Text-messaging (SMS, WeChat etc)-Based Interventions (650) mHealth for Treatment Adherence (397) Cardiovascular Disease Prevention (137)

Published on in Vol 7, No 11 (2018): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/11289, first published .
The Ready to Reduce Risk (3R) Study for a Group Educational Intervention With Telephone and Text Messaging Support to Improve Medication Adherence for the Primary Prevention of Cardiovascular Disease: Protocol for a Randomized Controlled Trial

The Ready to Reduce Risk (3R) Study for a Group Educational Intervention With Telephone and Text Messaging Support to Improve Medication Adherence for the Primary Prevention of Cardiovascular Disease: Protocol for a Randomized Controlled Trial

The Ready to Reduce Risk (3R) Study for a Group Educational Intervention With Telephone and Text Messaging Support to Improve Medication Adherence for the Primary Prevention of Cardiovascular Disease: Protocol for a Randomized Controlled Trial

Authors of this article:

Jo L Byrne1 Author Orcid Image ;   Helen M Dallosso1 Author Orcid Image ;   Stephen Rogers2, 3 Author Orcid Image ;   Laura J Gray2 Author Orcid Image ;   Ghazala Waheed4 Author Orcid Image ;   Prashanth Patel5, 6 Author Orcid Image ;   Pankaj Gupta5, 6 Author Orcid Image ;   Yvonne Doherty1, 7 Author Orcid Image ;   Melanie Davies4 Author Orcid Image ;   Kamlesh Khunti4 Author Orcid Image
Article Authors Cited by (4) Tweetations (2) Metrics

Jo L Byrne   1 , RN, PhD ;   Helen M Dallosso   1 , PhD ;   Stephen Rogers   2, 3 , MSc, MB, MD ;   Laura J Gray   2 , PhD ;   Ghazala Waheed   4 , MSc ;   Prashanth Patel   5, 6 , FRCP, FRCPath ;   Pankaj Gupta   5, 6 , FRCP, FRCPath ;   Yvonne Doherty   1, 7 , BSc (Hons), MSc, D Clin Psych ;   Melanie Davies   4 , CBE, MB, ChB, MD, FRCP, FRCPGP, FMedSci ;   Kamlesh Khunti   4 , FRCGP, FRCP, MD, PhD, FMedSci

1 Leicester Diabetes Centre, University Hospitals of Leicester National Health Service Trust, Leicester, United Kingdom

2 Department of Health Sciences, University of Leicester, Leicester, United Kingdom

3 Innovation and Research Unit, Northamptonshire Healthcare Foundation Trust, Northampton, United Kingdom

4 Diabetes Research Centre, University of Leicester, Leicester, United Kingdom

5 Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom

6 Department of Clinical Pathology and Metabolic Sciences, University Hospitals of Leicester National Health Service Trust, Leicester, United Kingdom

7 York Diabetes Centre, York Teaching Hospital National Health Service Foundation Trust, York, United Kingdom

Corresponding Author:

  • Kamlesh Khunti, FRCGP, FRCP, MD, PhD, FMedSci
  • Diabetes Research Centre
  • University of Leicester
  • Leicester General Hospital
  • Leicester, LE5 4PW
  • United Kingdom
  • Phone: 44 116-258-4005
  • Email: kk22@leicester.ac.uk